ARTICLE | Clinical News
A4250 regulatory update
November 12, 2012 8:00 AM UTC
FDA granted Orphan Drug designation to Albireo's A4250 to treat progressive familial intrahepatic cholestasis (PFIC) and primary biliary cirrhosis (PBC). The company plans to move the compound, an inh...